Patent · US Expired

Agents and methods for treatment and diagnosis of ocular disorders

US6773916B1 · kind B1 · utility

61Cited by

2References

64Claims

0Family size

Assignee

The Flinders University of South Australia · AU

Inventors

Michael Thiel · Blankenloch, DE
Heddy Zola
Douglas Coster · Adelaide, AU
Keryn Williams · Kingswood, AU

Key dates

Filing date	Sep 19, 2001
Grant date	Aug 10, 2004
Priority date	—
Expiry date	Sep 19, 2021

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/624
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating an ocular disorder is disclosed, comprising administering to a patient in need of such treatment, an effective amount of a sub-immunoglobulin antigen-binding molecule that is immuno-interactive with a target antigen associated with the disorder. The invention is also directed to compositions comprising this sub-immunoglobulin antigen-binding molecule and to a method of diagnosing an ocular condition using such molecule.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.